Compare Stocks → AI to Meet the Same Fate as EVs? (From Porter & Company) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CHEKOTCMKTS:ECIAOTCMKTS:MYDP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEKCheck-Cap$3.08+12.0%$2.12$1.25▼$4.63$18.02M0.21256,348 shs274,415 shsECIAEncision$0.75+50.0%$0.46$0.25▼$0.75$8.84M0.282,177 shs100 shsMYDPDougherty's Pharmacy$0.02$0.02$0.00▼$0.02N/AN/AN/A9,000 shs(Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEKCheck-Cap+11.34%+33.43%+22.77%+26.15%+89.66%ECIAEncision0.00%0.00%+9.17%+20.95%+19.33%MYDPDougherty's Pharmacy0.00%0.00%0.00%0.00%0.00%AI to Meet the Same Fate as EVs? (Ad)When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEKCheck-Cap1.8264 of 5 stars3.03.00.00.03.00.01.3ECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/AMYDPDougherty's PharmacyN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEKCheck-Cap2.00Hold$7.00127.27% UpsideECIAEncisionN/AN/AN/AN/AMYDPDougherty's PharmacyN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEKCheck-CapN/AN/AN/AN/A$8.57 per shareN/AECIAEncision$7.35M1.20N/AN/A$0.21 per share3.57MYDPDougherty's PharmacyN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEKCheck-Cap-$19.11M-$3.02N/AN/AN/AN/A-47.85%-43.50%3/29/2024 (Estimated)ECIAEncision-$320K-$0.04N/A∞N/A-6.51%-18.97%-10.50%6/20/2024 (Estimated)MYDPDougherty's PharmacyN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CHEK, SALV, MYDP, and ECIA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/29/2024N/ACHEKCheck-CapN/A-$0.87-$0.87N/AN/AN/A2/14/2024Q3 2024ECIAEncisionN/A-$0.02-$0.02-$0.02N/A$1.58 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEKCheck-CapN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AMYDPDougherty's PharmacyN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEKCheck-CapN/A17.6017.60ECIAEncision0.112.551.08MYDPDougherty's PharmacyN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEKCheck-Cap1.07%ECIAEncision8.20%MYDPDougherty's PharmacyN/AInsider OwnershipCompanyInsider OwnershipCHEKCheck-Cap0.48%ECIAEncision40.87%MYDPDougherty's Pharmacy31.60%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCHEKCheck-Cap855.85 million5.82 millionNot OptionableECIAEncision3111.78 million6.96 millionNot OptionableMYDPDougherty's Pharmacy75N/AN/ANot OptionableCHEK, SALV, MYDP, and ECIA HeadlinesSourceHeadlineCharging foul call ends Albany Dougherty's comeback in the Final Fouralbanyherald.com - March 3 at 3:47 PM10 systems seeking pharmacy leadersbeckershospitalreview.com - February 22 at 6:48 PMCaitlin J. Doughertyhealth.usnews.com - January 19 at 12:42 PM73-year-old shot in head at Duran's Pharmacy speaks on shootingkoat.com - January 19 at 12:42 PMPharmacy Technician Salarymoney.usnews.com - January 13 at 6:33 PMAmy A. Doughertyhealth.usnews.com - December 16 at 10:50 AMFormer Philly labor leader Johnny Doc found guilty of 70 counts of fraud and embezzlementwhyy.org - December 14 at 10:19 AMAlbany Dougherty's David Burgess, Maurice Davis lead region honorsalbanyherald.com - December 13 at 4:08 PMAlbany Dougherty's David Burges, Maurice Davis lead region honorsalbanyherald.com - December 12 at 10:33 PMPharmD / MBAuwyo.edu - November 14 at 12:54 AMDoctor of Pharmacy Programuwyo.edu - November 14 at 12:54 AMJamie Doughertyhealth.usnews.com - November 3 at 10:51 PMKroger Pharmacy Reviewsconsumeraffairs.com - November 2 at 3:28 PMWalgreens pharmacy employees plan walkout at US stores: reportnypost.com - October 10 at 9:26 AMWalgreens Pharmacy Reviewsconsumeraffairs.com - September 28 at 5:39 PM9 Candidates Vying for Judge in Macon, Coweta, Atlantic, Dougherty Circuitslaw.com - September 26 at 12:35 PMThe Next Lost Causenationalreview.com - September 22 at 6:24 AMMary Jo Doughertyhealth.usnews.com - September 15 at 9:47 PMDiane L. Doughertyhealth.usnews.com - September 9 at 10:15 PMDougherty's Kam Davis earns "Super 11" award, best player in Class AAA againalbanyherald.com - August 12 at 6:08 PM‘Been very blessed’: Ridley Park man inducted into Pro Football Hall of Fame for video workdelcotimes.com - August 8 at 7:48 AMBest Student Loans For Pharmacy School Of July 2023forbes.com - August 3 at 10:00 AMAn Australian Photographer Was Disqualified From a Photo Contest After Her Submission Was Mistakenly Deemed A.I.-Generatednews.artnet.com - July 23 at 2:16 PMDr. Thomas R. Doughertyhealth.usnews.com - July 19 at 5:22 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsCheck-CapNASDAQ:CHEKCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.EncisionOTCMKTS:ECIAEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Dougherty's PharmacyOTCMKTS:MYDPDougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.